EFMC Sponsored Events are scientific events or post-graduate educational activities related to Medicinal Chemistry or Chemical Biology organised by EFMC national adhering organisations*, EFMC partner organisations, non-for-profit associations or scientific committees.

Applications for sponsorship should be done by sending the below form to the EFMC Administrative Secretariat (administration@efmc.info), at least three months prior to the event for both physical and online events. In case of smaller online events, we will accept requests up to a month prior to the event.

Sponsorship applications will be considered by the EFMC Executive Committee before approval. Sponsorship will not be granted to events overlapping with EFMC organised events.

*EFMC national adhering organisations are granted EFMC sponsorships at no costs, provided the event fulfills the requirements.

September 26-30, 2022Heidelberg, Germany

The EuroQSAR Symposia have been taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences. The 23rd European Symposium on Quantitative Structure-Activity Relationship will take place from September 26-30, 2022 in Heidelberg, Germany.

This edition, initially scheduled in 2020 in Barcelona, postponed to 2021 due to the Coronavirus pandemic, is now finally planned for 2022 as a face-to-face meeting in Heidelberg.

The 23rd EuroQSAR Symposium, entitled “Integrative Data-Intensive Approaches to Drug Design”, is organised on behalf of QCMS and is chaired by Prof. Rebecca Wade (Heidelberg University and HITS, Heidelberg, Germany).


  • Deadline for Oral Communication and Early-Bird registration: June 7, 2022
  • Deadline for Poster Submission: August 4, 2022


  • QSAR without Borders
  • Artificial Intelligence in Drug Design
  • Molecular Dynamics and Kinetics
  • Chemical Space Annotation and Expansion
  • Modelling Drug Safety
  • Challenges in GPCR Drug Design
  • Modelling Drug Transport Mechanisms
  • Predicting Off-Target Pharmacology
  • Network Medicine
  • New Modes of Target Interaction
  • New Trends in Quantum Mechanics
  • Future Challenges Ahead

Confirmed Invited Speakers:

  • Dr Dimitris AGRAFIOTIS (Novartis, United States)
  • Prof. Rommie AMARO (University of California, United States)
  • Prof. Olivier ELEMENTO (Cornell University, United States)
  • Prof. Marta FILIZOLA (Icahn School of Medicine at Mount Sinai, United States)
  • Dr Oliver KOCH (University of Münster, Germany)
  • Prof. Tudor I. OPREA (Riovant Discovery, United States)
  • Prof. Maria Joao RAMOS (University of Porto, Portugal)
  • Prof. Matthias RAREY (University of Hamburg, Germany)
  • Prof. Sereina RINIKER (ETH Zürich, Switzerland)
  • Dr Alessandra RONCAGLIONI (Mario Negri Institute for Pharmacological Research, Italy)
  • Prof. Julio SAEZ-RODRIGUEZ (Heidelberg University, Germany)
  • Dr Gary TRESADERN (Janssen, Belgium)

Discover the full programme.

For more information please contact: 
Symposium Secretariat
LD Organisation srl
Rue Michel de Ghelderode 33/2
B-1348, Louvain-la-Neuve, Belgium 
Phone: +32 10 45 47 77
E-mail: secretariat@ldorganisation.com

October 5-7, 2022Verona, Italy

The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to be holding this 8th meeting in the series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.

The meeting will consist of:

  • Case studies in GPCR drug discovery and development
  • Structural biology advances and impact on drug design
  • Showcasing multiple modalities and drug discovery approaches to modulating GPCRs
  • Also: poster session – trade exhibition opportunities – two evening dinners and vineyard visit – accommodation agency booking service.

Registration Fees

Registration is open, and you may register via this link. There is an option for Exhibitor and Sponsor registrations at the foot of the registration page, and you may pay by card or request an invoice for settlement by bank transfer.

Organising Committee:

  • Daniele Andreotti, Evotec
  • Adrian Hall (co-chairman), UCB
  • Duncan Hay (treasurer), Vertex
  • Caroline Low (co-chairman), Consultant
  • Nigel Swain, Sosei Heptares
Contact person: Maggi Churchouse (Mrs)

Organised by: RSC BMCS/SCI FCG

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

November 23-26, 2022Virtual Event

Dear colleagues,

We are pleased to inform you that the 12th Joint Meeting on Medicinal Chemistry 2022 Organizing Committee has decided on a new date. The Virtual Meeting will be held on the 23-26 NOVEMBER, 2022.

The registration and abstract submission is already open, so do not miss the opportunity to share your work and get new knowledge from the experts.

Main Topics:

  • Organic Chemistry – New Insights into Drug Development
  • Metabolic Disorder Related Diseases and Their Treatment
  • Neurodegenerative Diseases
  • New compounds in Combating Infectious Diseases
  • Drug Metabolism


Have a look at the list of speakers


Abstract deadline is September 18, 2022


For more information please contact: jmmc2022@guarant.cz

With our best regards and hope to meet all of you during our virtual JMMC 2022!

JMMC 2022 Organising Committee

Organised by: GUARANT International spol. s r.o. (Czech Republic)